Guidance

Adolescent vaccine coverage collection (HPV and MenACWY and Td/IPV) annual survey: 2023 to 2024

Updated 6 November 2024

Introduction to the guide

Purpose of this document

The purpose of this document is to provide NHSE regional immunisation teams with detailed guidance on how to submit data for the 2023 to 2024 adolescent vaccine coverage collection annual survey. This survey is submitted via the ImmForm web-based system provided by the UK Health Security Agency (UKHSA).

ImmForm is the web-based system that provides vaccine ordering facilities for the NHS and is used by UKHSA to record vaccine coverage data for some immunisation programmes. See Appendix 1.

Survey quick start instructions

Full guidance on accessing and submitting the annual survey collection form can be found in Chapter 3 but here is a summary of instructions for entering and submitting HPV, MenACWY and Td/IPV data for the adolescent survey:

1. Log on to the ImmForm website.

2. Select ‘Data Collections’, then select ’Adolescent’.

3.Then select ‘Current Surveys’.

4. Then select ‘HPV and MenACWY and Td/IPV Booster Uptake 2023 to 2024 Annual Survey’.

5. Select the local authority you want to provide data.

6. NHSE regional immunisation teams and data providers can enter data to:

• update their local authority denominators for each cohort as appropriate
• provide information about the number of each cohort who have received HPV, MenACWY and Td/IPV vaccines
• provide information on where the vaccines were delivered
• provide information on catch-up of students who missed vaccinations in previous academic years
• comment on local issues that may have impacted data quality

7. Complete the relevant sections of the form.

8. Once all data is entered, select ‘Submit’ in the ‘Actions’ box.

9. Review any flagged validation warnings that may have appeared in the ‘Survey Form’ box.

10. Once you are satisfied that the data is accurate, select ‘Yes’ from the ‘Actions’ box.

11. Once the form has been submitted successfully, you will see the message: ‘Thank you for submitting data for this survey on [current date]’. Make sure you see this confirmation, otherwise the data have not been uploaded correctly.

12. If you wish to enter data for another local authority, return to step 2 above.

Chapter 1. Overview of the HPV, MenACWY and Td/IPV adolescent immunisation programmes and the vaccine coverage collection

Purpose of the adolescent vaccine coverage (HPV, MenACWY and Td/IPV) 2023 to 2024 annual survey

The human papillomavirus (HPV), meningococcal A, C, W and Y (MenACWY) and tetanus, diphtheria and inactivated polio (Td/IPV) vaccines are offered to adolescents in school years 8 to 10 (students aged between 12 and 15 years) in secondary school settings.

The ability to reliably measure vaccine coverage plays an essential role in evaluating the success of the HPV, MenACWY and Td/IPV immunisation programmes, identifying susceptible populations for further interventions and informing future vaccine policy decisions. This is dependent on having an accurate estimate for the eligible population (denominator) and a robust method of ascertaining the number of eligible individuals who have received doses of HPV, MenACWY and Td/IPV vaccines (numerators). This standardised vaccine coverage information can be made available at the local level creating the opportunity to compare local figures with regional and national estimates, improve coverage and detect changes in vaccine coverage year on year.

Sub-indicators in the Public Health Outcomes Framework (PHOF) will include HPV coverage for a dose at 12 to 13 years of age for both males and females, for a dose at 13 to 14 years of age for males and females and a dose for MenACWY for all adolescents aged 14 to 15 years old.

UKHSA also has commitments to report vaccine coverage figures to international organisations such as the World Health Organization (WHO). At the local level coverage statistics are used for local performance management and service delivery planning.

HPV immunisation programme

The national HPV immunisation programme was introduced in 2008 for secondary school year 8 females (12 to 13 years of age) as a 3-dose schedule. In March 2014, the Joint Committee on Vaccination and Immunisation (JCVI) advised a change from a 3 to a 2-dose schedule in the routine programme, which was implemented in September 2014.

In England, for operational purposes, the recommendation is to offer the first HPV vaccine dose to females in year 8 and the second dose 12 months later in year 9, as this reduces the number of immunisation sessions required in schools. However, some local areas schedule the second dose within year 8, from 6 months after the first dose.

From September 2020, the HPV immunisation programme was expanded to a universal programme with 12 to 13 year old males becoming eligible alongside females. Therefore, starting in the academic year 2019 to 2020, males in year 8 (cohort 1 in the ImmForm collection) were offered the HPV vaccine (either 1 or 2 doses) for the first time. In the academic year 2020 to 2021, the programme followed cohort 1 into year 9 in the same way as was done for the female HPV programme.

The 2023 to 2024 adolescent survey will collect HPV coverage data for school years 8 (cohort 21) and 9 (cohort 20) for females and school years 8 (cohort 5) and year 9 (cohort 4) for males.

MenACWY immunisation programme

MenACWY vaccine was introduced in 2015 to respond to a rapid and accelerating increase in cases of invasive meningococcal group W (MenW) disease, which had been declared a national incident. The MenACWY conjugate vaccine provides direct protection to the vaccinated cohort and, by reducing MenW carriage, also provides indirect protection to unvaccinated children and adults.

MenACWY vaccine was added to the routine adolescent schools programme (school year 9 or 10) from autumn 2015, as a direct replacement for the MenC vaccine. All those in school years 10 (not covered by the routine programme) to 13 in the 2014 to 2015 academic year were targeted for a catch-up programme. There was an urgent catch-up campaign (school year 13 in 2014 to 2015) through general practice from August 2015. A catch-up campaign (school year 11 in 2015 to 2016, school year 11 in 2016 to 2017) through schools began in January 2016. A further catch-up campaign through general practice (school year 13 in 2015 to 2016 and in 2016 to 2017) captured those who had been years 11 and 12 in 2014 to 2015. From August 2015 MenACWY was also included in the time-limited ‘freshers’ programme (direct replacement of the meningococcal C (MenC) vaccination, offered up to age 25) through general practice and, subsequently, those who missed MenACWY vaccine remained eligible to their 25th birthday.

The first survey collected 2015 to 2016 local authority coverage data for both the catch-up campaign, school year 11 (cohort 1), and the first year of MenACWY inclusion in the routine adolescent schools programme, school year 10 (cohort 2) or school year 9 (cohort 3) depending on local arrangements (see Appendix 4 and Appendix 5 for links to published data). In 2016 to 2017 local authorities provided coverage data for routine cohorts school year 9 (cohort 4) and 11 (cohort 2) or school year 9 (cohort 4) and 10 (cohort 3) according to the programme options detailed on page 8 of the Joint NHS England and UKHSA letter providing information on the introduction of Meningococcal ACWY conjugate vaccination (MenACWY) (see Appendix 4). Since the 2017 to 2018 adolescent survey, the annual surveys have collected MenACWY coverage data for school years 9 and 10.

The 2023 to 2024 adolescent survey will collect MenACWY coverage data for school years 9 (cohort 11) and 10 (cohort 10).

Td/IPV immunisation programme

A booster dose of tetanus and polio vaccine has been routinely offered at around 14 years of age for many years. Since 1994 a booster dose of low-dose diphtheria vaccine has also been offered at this age. Since 2004 the vaccine has been a combined tetanus/low dose diphtheria/inactivated polio vaccine (Td/IPV). Total numbers of children aged 13 to 18 years (aggregate) receiving a ‘reinforcing dose’ of Td/IPV (without denominator data) were published annually (the KC50 data collection) up to and including 2011 to 2012 until this collection was suspended. More detailed mandatory KC50 collections were attempted in 2010 to 2011 and 2011 to 2012 to include numbers of eligible children but the quality of the data was variable. A voluntary survey was conducted via email with NHS England Area Team (AT) Screening and Immunisation Leads (SILs) during the summer of 2014 to investigate whether it was possible to collect local authority level coverage data from areas where school-based Td/IPV vaccination programmes were undertaken. National data collection for this survey was piloted from 2015 to 2016 and has continued in subsequent years.

The 2023 to 2024 collection is the eighth year Td/IPV data will be collected for school year 9 (cohort 11) and/or year 10 (cohort 10), depending on local arrangements.

Updates to the 2023 to 2024 survey

For the 2023 to 2024 survey, we will be collecting HPV coverage for a dose among both year 8, year 9 and year 10 males and females. Updates to the survey include the revision of dates to questions and headers to improve clarity. There are additional questions to capture information on the delivery of the programme in the 2023 to 2024 academic year.

To understand any barriers in delivery of the programme, there are new questions in regard to whether any schools could not be accessed in the academic year. To help our understanding of the comparability of coverage estimates in different areas we have also established new questions on the source and definition of the denominator (the number of eligible children included).

Optional end of academic year school level data collection

At the end of each academic year, local authorities are requested to submit vaccine coverage data for each school participating in the adolescent immunisation programmes. Data can be returned using either the data collection tool provided by UKHSA at the beginning of the season or local data collection tools and spreadsheets. Submission of this data is optional.

UKHSA’s national vaccine coverage team within the Immunisation and Vaccine Preventable Diseases Division would be grateful for voluntary submission of school level data, during the local authority level data submission period, via email to adolscent@ukhsa.gov.uk

This data will be used to facilitate the assessment of data quality captured at the local authority level, to inform collections going forward, and to inform measures of inequalities in coverage, helping work towards the delivery of an equitable programme as outlined by the Public Health Functions Agreement (section 7a).

The data items requested for each school by relevant year group are the same as for the local authority level adolescent coverage collection: denominators (that is the total number of students eligible for the vaccine in the school year) and the total number of students vaccinated for each of the adolescent vaccines (a dose for HPV, a dose of MenACWY and a dose of Td/IPV).

Chapter 2. Adolescent vaccine coverage collection 2023 to 2024 local authority annual survey

Dates the collection is open

The adolescent vaccine coverage collection 2023 to 2024 local authority annual survey will be open from Monday 7 October 2024 until Monday 4 November 2024.

Annual vaccine coverage and delivery model information is requested for each local authority, via the ImmForm website, for vaccinations administered up to 31 August 2024.

Roles and responsibilities

NHSE regional immunisation teams should identify a member or members of the team to take on responsibility for:

• confirming the data entry fields required
• coordinating collation of local data from providers, which should be checked for completeness and accuracy (some local providers have ImmForm access and can enter their data directly on the survey)
• entering data for all local authorities in the area onto ImmForm by the survey deadline

Cohorts

Table 1. 2023 to 2024 cohort definitions and reporting requirements for adolescent immunisation programmes (HPV, MenACWY and Td/IPV) by school year

Programme	Cohort number	School year	Age (years)	Dates of birth	Eligible group	Dose 1 numerator	Dose 2 numerator
HPV (female)	21	Year 8	12 to 13	1 Sep 2010 to 31 Aug 2011	Females only	Provided by all local authorities	Provided by local authorities offering both doses in year 8
HPV (female)	20	Year 9	13 to 13	1 Sep 2009 to 31 Aug 2010	Females only	Updated for 2023 to 2024 by all local authorities	Provided by all Local authorities
HPV (female)	19	year 10	13 to 14	1 Sep 2008 to 31 Aug 2009	Females only	Updated for 2023 to 2024 by all local authorities	Updated for 2023 to 2024 by all local authorities
HPV (male)	5	year 8	12 to 13	1 Sep 2010 to 31 Aug 2011	Males only	Provided by all local authorities	Provided by local authorities offering both doses in year 8
HPV (male)	4	year 9	13 to 14	1 Sep 2009 to 31 Aug 2010	Males only	Updated for 2023 to 2024 by all local authorities	Updated for 2023 to 2024 by all local authorities
HPV (male)	3	year 10	14 to 15	1 Sep 2008 to 31 Aug 2009	Males only	Updated for 2023 to 2024 by all local authorities	Updated for 2023 to 2024 by all local authorities
MenACWY and Td/IPV	11	year 9	13 to 14	1 Sep 2009 to 31 Aug 2010	All students	Provided by all local authorities offering vaccines in year 9	Not applicable
MenACWY and Td/IPV	10	year 10	14 to 15	1 Sep 2008 to 31 Aug 2009	All students	Provided by all local authorities offering vaccines in year 10	Not applicable

Denominators

Pre-filled or provisional denominators

The pre-filled denominators have been populated with data submitted in last year’s annual HPV or MenACWY and Td/IPV coverage surveys if available or with data derived from the annual Department for Education schools census data.

NHSE regional immunisation teams are requested to update the denominators to provide actual pupil numbers and account for movements in or out of the local authority or schools during the academic year.

The denominator is the number of adolescents in the school years described in Table 1 in the following types of schools in each local authority:

• all schools managed by a local authority, including independent and faith schools
• schools managed by voluntary or private agents
• grant maintained schools
• pupil referral units
• secure units
• residential units
• schooled at home

And all adolescents of the ages specified in Table 1 who reside in the local authority but are not linked to any school.

Child Health Information System denominator

For areas extracting data from Child Health Information Systems the denominator is:

• all adolescents in the school years described in Table 1 at any of the above listed schools in the local authority (minus any resident adolescents attending school outside the local authority)
• all adolescents of the ages specified in Table 1 resident in the local authority not linked to any school

Numerators

HPV vaccines administered to year 8 (female cohort 21 and male cohort 5)

In section 1c, the pre-filled numerators are the number of females and males vaccinated with one dose whilst they were in school year 8 as of 28 September 2023 (taken from data submitted to the HPV vaccine coverage annual survey 2022 to 2023.

NHSE regional immunisation teams are required to update the pre-filled numerators from 2022 to 2023, where possible, to provide the total numbers of females and males vaccinated with a dose of HPV at any time up to 31 August 2024, including vaccines given both when they were in year 8 and year 9. It is important to include those vaccinated elsewhere if they have moved into schools in your local authority and remove those vaccinated previously in schools in your local authority who have since moved out.

If your local authority has the resources to include doses that were offered outside of the routine school programme, please include these in the numerator and indicate you have done so in by ticking the correct box and/or using the text box at the end of the survey (Figure 7). Please ensure that you do not add any personal identifiable data.

HPV vaccines administered to year 9 (female cohort 20 and male cohort 4)

In section 1e the pre-filled numerators are the number of females and males vaccinated with a dose as of 28 September 2022 (taken from data submitted to the HPV vaccine coverage annual survey 2022 to 2023). Data providers or NHSE regional immunisation teams are required to update the pre-filled numerators from 2022 to 2023, where possible, to provide the total numbers of females and males vaccinated with at least a dose of HPV at any time up to 31 August 2024 (Figure 6).

If your local authority has the resources to include doses that were offered outside of the routine school programme, please include these in the numerator and indicate you have done so in by ticking the correct box or using the text box at the end of the survey (Figure 7). Please ensure that you do not add any personal identifiable data.

HPV vaccines administered to year 10 (female cohort 19 and male cohort 3)

In section 1e the pre-filled numerators are the number of females and males vaccinated with a dose as of 28 September 2022 (taken from data submitted to the HPV vaccine coverage annual survey 2022 to 2023). Data providers or NHSE regional immunisation teams are required to update the pre-filled numerators from 2022 to 2023, where possible, to provide the total numbers of females and males vaccinated with at least a dose of HPV at any time up to 31 August 2024 (Figure 6).

If your local authority has the resources to include doses that were offered outside of the routine school programme, please include these in the numerator and indicate you have done so in by ticking the correct box or using the text box at the end of the survey (Figure 7). Please ensure that you do not add any personal identifiable data.

MenACWY and Td/IPV vaccines administered to year 9 or 10 (cohort 10 and cohort 11)

To calculate local authority MenACWY and Td/IPV vaccine coverage for 2023 to 2024, the following data is required for section 2 of the survey for the cohorts described in Table 1:

• the number of adolescents who received 1 dose of the MenACWY vaccine by 31 August 2024
• the number of adolescents who received 1 dose of Td/IPV vaccine by 31 August 2024

The pre-filled numerators are the number of adolescents vaccinated last season as of 28 September 2023 (that is when the cohort was in year 9). For year 10 entry, section 2e, should include those vaccinated prior to, as well as during, the academic year 2023 to 2024.

It is important to include those vaccinated elsewhere if they have moved into schools in your local authority and remove those vaccinated in schools in your local authority who have since moved out. If your local authority has the resources to include doses that were offered outside of the routine school programme, please include these in the numerator and indicate you have done so in by ticking the correct box in the survey ([Figure 8]](#Figure8)). Please ensure that you do not add any personal identifiable data.

Please update the denominator and numerator for students in year 10 (section 1g), even if your area routinely delivers the programme in year 9, so that the most up to date coverage figure for this cohort can be calculated. While calculating this update please make sure to include both those that got vaccinated in the prior academic year (while in year 9) and in the latest academic year (in year 10) in the numerator.

Chapter 3. Guide to accessing and submitting the annual data collection form

Accessing the survey

Sign in to Immform to access this survey page. Once you have successfully logged onto the ImmForm website, you will need to select ‘Adolescent’ under the ‘Data Collections’ pane at the top left-hand side of the screen. (Figure 1).

Figure 1. ImmForm data collections pane on the home page

Under the ‘Current Surveys’ pane, select ‘HPV and MenACWY and Td/IPV Booster Uptake 2023 to 2024’ (Figure 2).

Figure 2. Selecting the 2022 to 2023 annual survey

If the account you are using has access to multiple local authorities, select the required local authority using the ‘OrgCode’ drop down menu. If the account has access to a singular local authority, this field will be automatically filled (Figure 3). Once the fields have been selected, select ‘Go’.

Submitting the data

You will be directed to the data form related to the local authority you have chosen. An example of the form can be seen in Figures 3 to 11. The form consists of 2 sections, section 1 (a to g) for HPV and section 2 (a to g) for MenACWY and Td/IPV.

In section 1a, please indicate whether all eligible children in year 8 were offered a dose of the HPV vaccine during the 2023 to 2024 academic year. Please use the text box at the end of the survey (section 1g) to add further information, for example, if only all females were offered a dose of HPV vaccine and you have yet to offer the vaccine to all males, or if there are any plans for catch-up.  Please ensure that you do not add any personal identifiable data.

For numerators in sections 1b, 1c and 1e for the HPV survey as well as 2d and 2e for MenACWY and Td/IPV surveys, please ensure you have included all children where you have been able to capture vaccine delivery. Please select the appropriate radio button for each of the different cohorts in regard to whether the numerator included children exclusively vaccinated in schools or includes children vaccinated in other settings. If you are not able to capture those offered vaccines delivered outside of the routine school programme, for example, for homeschooled children or children who attend faith schools where there is no programme or children who opt to go to their GP instead of getting the vaccine at school, then could you please let us know, in the text box at the end of the survey (sections 1f and 2g), who it is that you might be leaving out. Please ensure that you do not add any personal identifiable data.

Please remember to double check the denominators and numerators for the females and males in section 1b,1c and 1e before submission.

Figure 3. HPV section for year 8 females and males

In section 1d, please select one of the options to indicate whether the HPV programme has been completed for all eligible cohorts who missed out on vaccinations in the 2021 to 2022 academic year (1 September 2021 to 31 August 2022) and the 2022 to 2023 academic year (1 September 2022 to 31 August 2023). Please ensure that you do not add any personal identifiable data.

Figure 4. Question on whether the HPV vaccination programme in your area has been completed since COVID-19

Figure 5. HPV section for year 9 females and males

Figure 6. HPV section for year 10 females and males

In sections 1f and 2f, please specify the number of schools which immunisation providers were unable to attend, along with reasons, if applicable. Also, ensure you select the appropriate radio buttons to indicate the source of your denominator values.

Figure 7. Source of data

Figure 8. MenACWY and Td/IPV section

In section 2b, please indicate whether all eligible children in year 9 or 10 (depending on your programme delivery) were offered a dose of MenACWY and Td/IPV vaccine during the 2023 to 2024 academic year. Please use the text box at the end of the survey (section 2f) to add further information. Please ensure that you do not add any personal identifiable data.

To help you submit accurate data there are in-built validations within the ImmForm annual survey form to ensure mandatory data is entered and that the data is logically correct, for example:

• if the difference between the pre-filled denominator and the actual denominator is more than plus or minus 5% different, you will be required to add the reason for this change
• the number vaccinated with each vaccine must be less than or equal to the denominator

These validations are not exhaustive; they have been incorporated to assist with data entry and to reduce major errors from occurring. Data should still be checked fully before submission.

For further information about how UKHSA validate the adolescent survey data submitted, please see Appendix 2.

If there are no concerns regarding the quality of the data, these should be detailed in the ‘Comments’ box at the bottom of both the HPV and MenACWY and Td/IPV forms.

Once the form has been completed and checked, select ‘Submit’ in the ‘Actions’ box at the bottom of the screen (Figure 9).

Figure 9. Comments and actions box

The form will then notify you of any fields which have been flagged by inbuilt validation checks and require confirmation. These must be observed and reviewed. They can be found at the top of the page under the ‘Survey Form’ box (Figure 10). If the data is still correct despite the validation flags, select ‘Yes’ in the ‘Actions’ box.

Example of a validation error:

Figure 10 shows an example of a validation error. When you submit the report, if there is a validation error, you will be prompted. The example below shows that the number of children vaccinated is greater than the number of children eligible for the vaccine, therefore, vaccine coverage is greater than 100%. In order to submit, the numerator or denominator will need to be corrected to achieve correct coverage, less than or equal to 100%.

Figure 10. Validation flags

You will then be taken to the confirmation page (Figure 11). If you do not see this page, your data have not been submitted. The date of submission and a message will be displayed notifying you of a successful submission. You have the options of ‘Click here to email submission confirmation’ to receive a confirmation by email that a submission has been processed, and ‘Click here to export the data you have saved to Excel’ to download an Excel table containing the data you have just submitted. Finally, select ‘OK’ to return to the home screen.

Figure 11. Confirmation screen

Co-ordinating data submission within an NHSE regional immunisation team

Where different members of NHSE regional immunisation team or local providers are submitting individual local authority spreadsheets, it is important to identify one person in the team to check that data have been submitted for all local authorities that the team is responsible for before the end of the data collection period (28 September 2024).

Amending data after it has been entered

You can return to the adolescent vaccine Uptake 2023 to 2024 – annual local authority collection screen and repeat the process to re-submit information that you may have previously entered, provided you do this within the submission and editing period. Please note: this will overwrite data previously uploaded.

Chapter 4. Information governance and publication

Information governance

The ImmForm survey collects numerical data for vaccine coverage and does not include individual patient identifiable data. Small numbers are suppressed in reports for publication in accordance with information governance guidelines.

The ImmForm database allows all NHSE regional immunisation teams staff who are registered with an ImmForm account, to access the survey during the data collection period.

Publication

National NHS England and local authority level data from the adolescent vaccine coverage collection 2023 to 2024 local authority annual survey will be published in late 2024 or early 2025 on the vaccine uptake guidance and the latest coverage data webpage.

Publishing data from ImmForm surveys

The data on ImmForm contains results collected from national surveys and collections. Any secondary analyses of unpublished data should apply accepted standards and guidance on data quality relating to the collection, analysis, publication or other dissemination of data and information. Any secondary analyses of unpublished data should be well described and obtained using a sound methodology and where possible produced in conjunction with official statistics or data already in the public domain. Please ensure you have taken into account all appropriate caveats when interpreting the data and reference the source in any subsequent reproductions or analyses of data.

Pre-release access is subject to terms of protecting patient privacy and confidential information in relation to the legitimacy of the data request for the purpose of the effective discharge of official functions and research. The terms are:

• not to disclose or share without prior agreement, any part of the data that includes unpublished data until official statistics have been published
• not to use access for personal gain or take any action for political advantage
• not to use access to change or compromise the content, presentation or the timing of publication of the data

The use of the data must be consistent with the condition of supply.

Queries

Check this user guide in the first instance, as the information contained will cover the majority of questions. For queries regarding survey data collection content and process not covered in official correspondence, or this user guide, please email adolescent@ukhsa.gov.uk

Every attempt is made to respond to all queries received via the UKHSA mailbox as quickly as possible, but due to the number of email queries received at the start of the survey, there may be minor delays in responding.

Appendix 1. ImmForm

ImmForm is the system used by the NHS and UKHSA to collect data on vaccine uptake for immunisation programmes and provide vaccine ordering facilities for the NHS. ImmForm is easy to access, is password protected, and allows registered customers to submit, analyse and review their vaccine coverage data.

Service hours

ImmForm service hours are 9am to 5pm Monday to Friday (excluding Bank Holidays). Although the website is usually available outside of these hours, essential maintenance can be conducted during this time and therefore the website may become unavailable without notice.

Data providers should also monitor the ‘News items’ section of the website where timely information about individual surveys and important messages for GP practices or NHS England team Screening and Immunisation co-ordinators will be posted as and when necessary.

Main contacts

If you have any questions regarding the adolescent vaccine coverage data collection process, please use the feedback facility function on the ImmForm website or email adolescent@ukhsa.gov.uk

To request passwords or amendments to your ImmForm account please email the ImmForm Helpdesk at helpdesk@immform.org.uk or contact them by phone at 0844 376 0040.

Appendix 2. How UKHSA validate the adolescent survey data

The guide has given examples of validation checks conducted on the local authority data during data entry on the ImmForm website.

Once local authority data has successfully been submitted to ImmForm, UKHSA will conduct further validity checks on the 2023 to 2024 data set as follows:

• compare data with the published 2022 to 2023 data and review the reasons for any changes in vaccine coverage
• where the percentage change in the denominator is plus or minus 10% or more, UKHSA will contact the appropriate data provider in the NHS England team to seek an explanation for the increase or decrease

UKHSA will also contact the NHSE regional immunisation teams that have not submitted data for all their local authorities to request that they submit this data and, if they are unable to, to give a reason why.

Appendix 3. Responses for data providers

News items on ImmForm

News Items is a section of the ImmForm website where we can post timely information to particular users about arising matters. Please keep an eye on this section, as we will post important messages here for NHSE regional immunisation teams regarding this and other surveys.

Mandatory for local teams or SITs to provide the data

Section 1 (year 8, year 9 and year 10 HPV coverage) is a mandatory collection operated by UKHSA and has been accessed by the Data Alliance Partnership Board (DAPB0133 Amd 58/2022). The data collection is a vital part of the enhanced surveillance in place to measure the impact of the immunisation programme on diseases caused by HPV.

This is the ninth year UKHSA has collected data for the MenACWY and Td/IPV immunisation programmes which now form part of the combined adolescent vaccine coverage survey. Due to varied local delivery of the MenACWY and Td/IPV immunisation programmes, there will be some missing information for some local authorities, and as such MenACWY and Td/IPV data will be considered experimental.

Data can be amended after it’s been entered

Data can be amended after it’s been entered but you can only do this during the period the survey is open (see Amending data after it has been entered.

This data can be used to help NHSE regional immunisation team performance manage HPV, MenACWY and Td/IPV immunisation

NHSE regional immunisation teams are encouraged to examine uptake rates and identify the differences between population groups and geographical areas in terms of completion rates and access. A closer examination of local data may reveal hidden variation and help prioritise action needed to improve uptake rates, particularly for those most in need of HPV and/or MenACWY and Td/IPV immunisation.

You cannot send paper returns

We are not accepting paper returns. All data must be submitted via the ImmForm website. Data sent via any means other than through the website, will not be accepted. This is in line with the NHS policy for transfers of data within the NHS to be sent electronically from 2005.

Excluding adolescents that have died during the programme

If the adolescent died during the year they should be excluded from the annual denominator and therefore excluded from the annual numerators where applicable.

When the annual data be published and where

The annual data will be published on the vaccine uptake page of the UKHSA website in late 2024 or early 2025.

How to register a colleague on ImmForm to submit data

Please email the ImmForm helpdesk at helpdesk@immform.org.uk

You will need to supply the name, surname, email address, telephone number, the particular data collection you need access to, and the local authority area or area they belong to.

How to delete your ImmForm account

Please email the ImmForm helpdesk at helpdesk@immform.org.uk to inform them that you would like to cancel your ImmForm account.

Who to contact if you need assistance filling in the survey form

For help completing the spreadsheet or survey form, email adolescent@ukhsa.gov.uk

For any technical issues regarding access or uploading to ImmForm, email the ImmForm helpdesk at helpdesk@immform.org.uk

Appendix 4. Information resources on the HPV immunisation programme

Joint letter providing information on the changes to the HPV immunisation programme (June 2020)

Advice for health professionals about the changes to the HPV vaccine schedule (June 2020)

HPV Chapter 18a, Green Book

NHS public health functions agreement 2020 to 2021 Service specification for the HPV programme

HPV vaccine coverage in England, 2008 to 2009 to 2013 to 2014: a review of the first 6 years of the 3-dose programme

Human papillomavirus (HPV) vaccine coverage estimates in England: 2022 to 2023

Joint NHS England and UK Health Security Agency letter providing information on the introduction of Meningococcal ACWY conjugate vaccination (MenACWY) (June 2015)

Changes to the meningococcal C conjugate (MenC) vaccine schedule 2013 to 2015 (June 2015)

Meningococcal chapter 22, Green Book

Meningococcal ACWY immunisation programme vaccine coverage estimates

Appendix 5. Information resources on the MenACWY immunisation programme

NHS Immunisation Statistics (England)

Tetanus (chapter 30), Diphtheria (chapter 15), Polio (chapter 26), Green Book

School leaver booster (Td/IPV) vaccine coverage estimates